According to Emergen Research, the global human microbiome modulators market size was USD 1.92 billion in 2020 and is expected to reach USD 6.10 billion in 2028 and register a revenue CAGR of 16.5% during the forecast period, 2021-2028.
Emergen Research has published its latest report titled “Human Microbiome Modulators Market, By Product (Prebiotics and Dietary Supplements, Probiotics and Creams, Drugs), By Application (Infections, Cancers, Neurological Disorders, Dermatological Diseases, Gastrointestinal Diseases, Metabolic Disorders), and By Region, Forecast to 2028”
According to Emergen Research, the global human microbiome modulators market size was USD 1.92 billion in 2020 and is expected to reach USD 6.10 billion in 2028 and register a revenue CAGR of 16.5% during the forecast period, 2021-2028.
Market Dynamics:
The global human microbiome modulators market has registered steady revenue growth over the last few years, owing to factors such as rising geriatric population around the world, increasing prevalence of chronic and acute diseases, rising burden of lifestyle-induced disorders such as high blood pressure, diabetes, and obesity, and rapid adoption of preventive medicine. Human microbiome modulation refers to the novel strategy that has been developed to reverse the commonly known technique of microbial dysbiosis. The new technique aids in the prevention and treatment of cancer, dermatological disorders, and gastrointestinal diseases such as colorectal cancer (CRC).
Revenue growth of the global human microbiome modulators market is further driven by increasing applications of the human microbiome modulation technique in development of advanced therapeutics for various infectious, oncological, neurological, dermatological, and gastrointestinal disorders, and rapid adoption of various human microbiome modulation strategies including probiotics, prebiotics, post-biotics, antibiotics, and fecal microbiota transplantation (FMT).
Click Here to Access Free sample PDF Copy of the Report@ https://www.emergenresearch.com/request-sample/376
COVID-19 Impact Analysis:
- Social distancing and restrictions severely disrupted businesses and operations
- Lockdowns caused disruptions in transportation and logistics
- Impacted manufacturing activities and mining operations globally
- Took a toll on economy of various countries
- Caused sudden and drastic downturn in economic activity
- Disrupted agriculture, fisheries, dairy, and other sectors
- Caused loss of employment and financial crisis
- Supply impacts were further compounded owing to reduced disposable income
- Emergence of variants continue to cause concerns and impact normal routines
Probiotics Segment Accounted for Largest Revenue Share in 2020:
Based on product type, the global human microbiome modulators market is segmented into prebiotics and dietary supplements, probiotics, creams, and drugs. The probiotics segment accounted for the largest revenue share in the global market in 2020, mainly owing to factors such as rise in geriatric population and growing prevalence of gastrointestinal and metabolic diseases such as irritable bowel syndrome, diarrhea, enterocolitis, colitis, and acute gastroenteritis. Increasing demand for probiotics due to their high effectiveness in improvement of the structure and function of the human microbiome is another key factor contributing to this segment’s growth.
Infectious Diseases Segment to Account for Fastest Revenue CAGR:
Among application segments, the infectious diseases segment is projected to register the fastest revenue growth rate in the global market over the forecast period. Rising incidences of infectious diseases, rapid shift from antibiotic therapeutics & drugs, increasing research activities involving human microbiome and clinical applications of novel therapeutics, and emergence of new target-specific microbiome-based therapies are the key revenue growth drivers.
North America Accounted for Largest Revenue Share in 2020:
Among regional markets, the North America human microbiome modulators market accounted for the largest revenue share in the global market in 2020. Rise in geriatric population, rising burden of acute and chronic diseases including cancer, diabetes, and high blood pressure, growing use of the human microbiome modulation technique in developing novel drugs and therapies for various neurological, infectious, oncological, and gastrointestinal diseases, and presence of key market players in the region, including DuPont de Nemours, Inc., Ingredion Incorporated, and Procter & Gamble Company, are major factors driving the regional market revenue growth.
Buy your Exclusive copy @ https://www.emergenresearch.com/select-license/376
Major Companies in the Market Include:
- Bayer AG
- DuPont de Nemours, Inc.
- Sanofi S.A.
- Procter & Gamble Company
- Koninklijke DSM N.V.
- Probi AB
- Immuron Ltd.
- BioGaia AB
- Ingredion Incorporated
- Yakult Honsha Co., Ltd.
For the purpose of this report, Emergen Research has segmented the global human microbiome modulators market based on product type, application, and region:
Product Type Outlook (Revenue, USD Billion; 2018-2028)
- Prebiotics and Dietary Supplements
- Probiotics
- Creams
- Drugs
Application Outlook (Revenue, USD Billion; 2018-2028)
- Cancer
- Infectious Diseases
- Neurological Disorders
- Dermatological Diseases
- Gastrointestinal Diseases
- Metabolic Disorders
Have a look at Report Description and Table of Contents of Market Report@ https://www.emergenresearch.com/industry-report/human-microbiome-modulators-market
Region Outlook (Revenue, USD Billion; 2018–2028)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa
- Saudi Arabia
- U.A.E.
- South Africa
- Turkey
- Rest of Middle East & Africa
Explore more Reports from Emergen Research:
Mobile Phlebotomy Services Market By Services (Process & Handling, Specimen Collection, Specimen Shipping), By Application (Cancer, Biosimilar, Vaccine Clinical Trials), By End-Use (Doctors & Nurses, Individuals, Medical Laboratories, and Others), and By Region Forecast to 2028
Life and Pensions Business Processing Outsourcing (BPO) Market By Type, By Services, By Organization Size, By Buyer Type, and By Region Forecast to 2028
Food Delivery Services Market Size, Share, Trends, By Platform (Online, Offline, Online to Offline (O2O)), By Model (Platform to Customer, Aggregators, Full-Stack Model, Restaurant to Consumer Model), By Type, By Application, and By Region Forecast to 2028
Top Food Delivery Services Companies in the World
Top 10 Leading Companies In The Low-cost Satellites Market
Top 10 Leading Cloud TV Companies in The World
Top 10 Companies in the Drone Package Delivery Industry
World Top 10 Companies Offering Artificial Intelligence in BFSI
About Emergen Research
Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Emergen Research has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
Eric Lee
Corporate Sales Specialist
Emergen Research | Web: www.emergenresearch.com
Direct Line: +1 (604) 757-9756
E-mail: sales@emergenresearch.com
Visit for More Insights: https://www.emergenresearch.com/insights
Explore Our Custom Intelligence services | Growth Consulting Services
Read Full Press Release@ https://www.emergenresearch.com/press-release/global-human-microbiome-modulators-market